Baseline Findings from Dual-Phase Amyloid PET Study in Newly Diagnosed Multiple Sclerosis: Exploring Its Potential as a Biomarker of Myelination and Neurodegeneration Barrios-López, Jose María Triviño-Ibañez, Eva María Piñeiro-Donis, Adrian Segovia-Román, Fermin Pérez García, Maria del Carmen Marín-Romero, Bartolomé Romero Villarrubia, Ana Guillén Martínez, Virginia Martinez-Barbero, José Pablo PIñar Morales, Raquel Barrero Hernández, Francisco Javier Minguez-Castellanos, Adolfo Gómez-Rio, Manuel 2025-11-03T11:18:58Z 2025-11-03T11:18:58Z 2025-11-01 journal article Barrios-López, J.M.; Triviño-Ibáñez, E.M.; Piñeiro-Donis, A.; Segovia-Román, F.; Pérez García, M.d.C.; Marín-Romero, B.; Romero Villarrubia, A.; Guillén Martínez, V.; Martínez-Barbero, J.P.; Piñar Morales, R.; et al. Baseline Findings from Dual-Phase Amyloid PET Study in Newly Diagnosed Multiple Sclerosis: Exploring Its Potential as a Biomarker of Myelination and Neurodegeneration. J. Pers. Med. 2025, 15, 520. https://doi.org/10.3390/jpm15110520 https://hdl.handle.net/10481/107702 10.3390/jpm15110520 eng http://creativecommons.org/licenses/by-nc-nd/4.0/ open access Attribution-NonCommercial-NoDerivatives 4.0 Internacional MDPI